{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:28:58Z","timestamp":1789043338622,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2020 National Fund Research (NRF) GRANT, 6TH Batch","award":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"],"award-info":[{"award-number":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"]}]},{"name":"2020 National Fund Research (NRF) GRANT, 6TH Batch","award":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"],"award-info":[{"award-number":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"]}]},{"name":"2020 National Fund Research (NRF) GRANT, 6TH Batch","award":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"],"award-info":[{"award-number":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"]}]},{"name":"2020 National Fund Research (NRF) GRANT, 6TH Batch","award":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"],"award-info":[{"award-number":["TETF\/DR & D\/CE\/NRE\/STI\/40\/VOL.1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Presently, there is no vaccine for hepatitis C virus (HCV) and available drugs present with adverse effects that have prompted the search for newer and safer alternatives. The present study evaluated the anti-HCV potential of selected bioactive compounds from\n                    <jats:italic>Jatropha tanjorensis<\/jats:italic>\n                    and\n                    <jats:italic>Solanum nigrum<\/jats:italic>\n                    against HCV non-structural (NS2-3) protein. The selected bioactive compounds (3-methoxy-4-methylaniline, 2,2\u2019-Azoxybis[3-methylpyridine], isopropyl thiophosphondiamide, and squalene) were screened for compliance with Lipinski\u2019s role five (LRF) and toxicity using the MCULE tool. Furthermore, the ligands were docked against the NS2-3 (2hd0) protein with ledipasvir, and a co-crystal as controls using the Autodock Vina tool. Docking scores were generated using the London dG scoring function. Following docking, a 200 nanosecond (nsec) simulation run was performed using the Schrodinger Desmond module. In addition, density functional theory (DFT) was utilised to evaluate their reactivities. The selected compounds were not toxic and obeyed the LRF. Molecular docking scores for ledipasvir and the co-crystal were \u2212\u20098.8 and \u2212\u20096.3\u00a0kcal\/mol, respectively while of the ligands ranged from \u2212\u20093.5 to -7.3\u00a0kcal\/mol, implying favourable bindings. The amino acid residues involved in the binding were those within the active site of the target protein. RMSD values indicated that isopropyl thiophosphondiamide was the most stable ligand. PSA, MolSA and SASA values suggest stability and availability for water contact. DFT calculations indicate that the compounds were moderately stable and highly reactive, with energy gaps that ranged from 0.5810 to 1.0621\u00a0eV. The favourable pharmacokinetics and docking outputs observed in this study needs to be further validated using in vitro and in vivo studies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-18577-8","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:24:25Z","timestamp":1771496665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-HCV NS2-3 potential of selected plant bioactive compounds revealed by docking, simulation and DFT"],"prefix":"10.1038","volume":"16","author":[{"given":"Clement I.","family":"Mboto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth N.","family":"Mbim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwem O.","family":"Edet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Lugos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohnad","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred O.","family":"Ndifon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eno E.","family":"Ebenso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel. I.","family":"Udo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry O.","family":"Egharevba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwem E.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-6853","authenticated-orcid":false,"given":"Mohamed H","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-8376","authenticated-orcid":false,"given":"Sami Fatehi","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"3","key":"18577_CR1","doi-asserted-by":"publisher","first-page":"101596","DOI":"10.1016\/j.clinre.2020.101596","volume":"45","author":"F Roudot-Thoraval","year":"2021","unstructured":"Roudot-Thoraval, F. Epidemiology of hepatitis C virus infection. Clin. Res. Hepatol. Gastroenterol. 45 (3), 101596 (2021).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"17","key":"18577_CR2","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3748\/wjg.v13.i17.2406","volume":"13","author":"J Dubuisson","year":"2007","unstructured":"Dubuisson, J. Hepatitis C virus proteins. World J. Gastroenterology: WJG. 13 (17), 2406 (2007).","journal-title":"World J. Gastroenterology: WJG"},{"issue":"1","key":"18577_CR3","first-page":"1","volume":"6","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Hepatitis C virus genotypes and subtypes Circulating in Mainland China. Emerg. Microbes Infections. 6 (1), 1\u20137 (2017).","journal-title":"Emerg. Microbes Infections"},{"key":"18577_CR4","doi-asserted-by":"crossref","unstructured":"Mboto, C. I. et al. In-silico evaluation of bioactive compounds from selected medicinal plants from Southern Nigeria against hepatitis C virus genotype 1 RNA-directed RNA polymerase. Sci. Afr. e01919. (2023).","DOI":"10.1016\/j.sciaf.2023.e01919"},{"key":"18577_CR5","doi-asserted-by":"crossref","unstructured":"Okoye, H. C. et al. Prevalence of Hepatitis C Virus in Nigeria (a Protocol for Systematic Review and Meta-analysis, 2021).","DOI":"10.21203\/rs.3.rs-144655\/v1"},{"issue":"3","key":"18577_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/09674845.2010.11730311","volume":"67","author":"CI Mboto","year":"2010","unstructured":"Mboto, C. I., Fielder, M., Davies-Russell, A. & Jewell, A. P. Hepatitis C virus prevalence and serotypes associated with HIV in the Gambia. Br. J. Biomed. Sci. 67 (3), 140\u2013144 (2010).","journal-title":"Br. J. Biomed. Sci."},{"issue":"2","key":"18577_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","volume":"4","author":"GS Cooke","year":"2019","unstructured":"Cooke, G. S. et al. Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol. Hepatol. 4 (2), 135\u2013184 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"9941","key":"18577_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0140-6736(14)60494-3","volume":"384","author":"IM Jacobson","year":"2014","unstructured":"Jacobson, I. M. et al. Simeprevir with pegylated interferon Alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet 384 (9941), 403\u2013413. https:\/\/doi.org\/10.1016\/S0140-6736(14)60494-3 (2014).","journal-title":"Lancet"},{"issue":"2","key":"18577_CR9","doi-asserted-by":"publisher","first-page":"e87077","DOI":"10.1371\/journal.pone.0087077","volume":"9","author":"W Xue","year":"2014","unstructured":"Xue, W., Yang, Y., Wang, X., Liu, H. & Yao, X. Computational study on the inhibitor binding mode and allosteric regulation mechanism in hepatitis C virus NS3\/4A protein. PLoS ONE. 9 (2), e87077. https:\/\/doi.org\/10.1371\/journal.pone.0087077 (2014).","journal-title":"PLoS ONE"},{"issue":"5424","key":"18577_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann, V. et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (5424), 110\u2013113 (1999).","journal-title":"Science"},{"issue":"1","key":"18577_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.20032","volume":"39","author":"F Penin","year":"2004","unstructured":"Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D. & Pawlotsky, J. M. Structural biology of hepatitis C virus. Hepatology 39 (1), 5\u201319 (2004).","journal-title":"Hepatology"},{"issue":"3","key":"18577_CR12","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1128\/jvi.67.3.1385-1395.1993","volume":"67","author":"ARASH Grakoui","year":"1993","unstructured":"Grakoui, A. R. A. S. H., Wychowski, C., Lin, C., Feinstone, S. M. & Rice, C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67 (3), 1385\u20131395 (1993).","journal-title":"J. Virol."},{"issue":"16","key":"18577_CR13","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1128\/JVI.00690-07","volume":"81","author":"CT Jones","year":"2007","unstructured":"Jones, C. T., Murray, C. L., Eastman, D. K., Tassello, J. & Rice, C. M. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 81 (16), 8374\u20138383 (2007).","journal-title":"J. Virol."},{"issue":"1","key":"18577_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/vaccines8010090","volume":"8","author":"JD Duncan","year":"2020","unstructured":"Duncan, J. D., Urbanowicz, R. A., Tarr, A. W. & Ball, J. K. Hepatitis C virus vaccine: challenges and prospects. Vaccines 8 (1), 90. https:\/\/doi.org\/10.3390\/vaccines8010090 (2020).","journal-title":"Vaccines"},{"key":"18577_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/v11020197","volume":"11","author":"KO Chang","year":"2019","unstructured":"Chang, K. O., Kim, Y., Lovell, S., Rathnayake, A. D. & Groutas, W. C. Antiviral drug discovery: Norovirus proteases and development of inhibitors. Viruses 11, 197. https:\/\/doi.org\/10.3390\/v11020197 (2019).","journal-title":"Viruses"},{"issue":"11","key":"18577_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1021\/acsinfecdis.6b00110","volume":"2","author":"H Freedman","year":"2016","unstructured":"Freedman, H., Logan, M. R., Law, J. L. M. & Houghton, M. Structure and function of the hepatitis C virus envelope glycoproteins E1 and E2: antiviral and vaccine targets. ACS Infect. Dis. 2 (11), 749\u2013762 (2016).","journal-title":"ACS Infect. Dis."},{"key":"18577_CR17","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3389\/fmolb.2020.613401","volume":"7","author":"S Vincent","year":"2020","unstructured":"Vincent, S., Arokiyaraj, S., Saravanan, M. & Dhanraj, M. Molecular Docking studies on the Anti-viral effects of compounds from Kabasura kudineer on SARS-CoV-2 3CLpro. Front. Mol. Biosci. 7, 2020. https:\/\/doi.org\/10.3389\/fmolb.2020.613401 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"18577_CR18","unstructured":"Shunmugam, L. In Silico investigation of hepatitis c virus: a novel perspective into targeted viral Inhibition of NS3 helicase, NS 3\/4a protease and NS5b RNA dependent RNA polymerase. (2019)."},{"key":"18577_CR19","doi-asserted-by":"crossref","unstructured":"Yen, H. H. et al. Pan-genotypic direct-acting antiviral agents for undetermined or mixed-genotype hepatitis C infection: a real-world multi-center effectiveness analysis. J. Clin. Med. 11(7), 1853 (2022).","DOI":"10.3390\/jcm11071853"},{"issue":"8","key":"18577_CR20","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/v2081635","volume":"2","author":"IC Lorenz","year":"2010","unstructured":"Lorenz, I. C. The hepatitis C virus nonstructural protein 2 (NS2): an Up-and-Coming antiviral drug target. Viruses 2 (8), 1635\u20131646. https:\/\/doi.org\/10.3390\/v2081635 (2010).","journal-title":"Viruses"},{"issue":"10","key":"18577_CR21","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.3390\/v4102197","volume":"4","author":"N Calland","year":"2012","unstructured":"Calland, N., Dubuisson, J., Rouill\u00e9, Y. & S\u00e9ron, K. Hepatitis C virus and natural compounds: a new antiviral approach? Viruses 4 (10), 2197\u20132217. https:\/\/doi.org\/10.3390\/v4102197 (2012).","journal-title":"Viruses"},{"issue":"8","key":"18577_CR22","first-page":"945","volume":"4","author":"RUB Ebana","year":"2019","unstructured":"Ebana, R. U. B. et al. Nutritional studies and antimicrobial activities of Jatropha tanjorensis leaves extracts against Escherichia coli isolates. Int. J. Innov. Sci. Res. Technol. 4 (8), 945\u2013955 (2019).","journal-title":"Int. J. Innov. Sci. Res. Technol."},{"key":"18577_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","volume":"35","author":"S Jo","year":"2020","unstructured":"Jo, S., Kim, S., Shin, D. H. & Kim, M. S. Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzyme Inhib. Med. Chem. 35, 145\u2013151. https:\/\/doi.org\/10.1080\/14756366.2019.1690480 (2020).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"18577_CR24","first-page":"14","volume":"1","author":"K Kitazato","year":"2007","unstructured":"Kitazato, K., Wang, Y. & Kobayashi, N. Viral infectious disease and natural products with antiviral activity. Drug Discov. Ther. 1, 14\u201322 (2007).","journal-title":"Drug Discov Ther."},{"key":"18577_CR25","unstructured":"Nirmaladevi, R., Ilango, S. & Jayachandran, P. In-Vitro Antioxidant Activity Of Annona muricata Leaves. J. Adv. Sci. Res. 12(01 Suppl 1), 32\u201341 (2021)."},{"key":"18577_CR26","unstructured":"World Health Organization. Interim guidance for country validation of viral hepatitis elimination. (2021)."},{"issue":"1","key":"18577_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12906-023-03841-z","volume":"23","author":"UO Edet","year":"2023","unstructured":"Edet, U. O. et al. Antimicrobial analysis of honey against Staphylococcus aureus isolates from wound, ADMET properties of its bioactive compounds and in-silico evaluation against dihydropteroate synthase. BMC Complement. Med. Ther. 23 (1), 39. https:\/\/doi.org\/10.1186\/s12906-023-03841-z (2023).","journal-title":"BMC Complement. Med. Ther."},{"issue":"1","key":"18577_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12906-022-03672-4","volume":"22","author":"UO Edet","year":"2022","unstructured":"Edet, U. O. et al. Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against capsular protein (Cap5O). BMC Complement. Med. Ther. 22 (1), 192. https:\/\/doi.org\/10.1186\/s12906-022-03672-4 (2022).","journal-title":"BMC Complement. Med. Ther."},{"issue":"44","key":"18577_CR29","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1039\/B608269F","volume":"8","author":"N Huang","year":"2006","unstructured":"Huang, N., Kalyanaraman, C., Bernacki, K. & Jacobson, M. P. Molecular mechanics methods for predicting protein\u2013ligand binding. Phys. Chem. Chem. Phys. 8 (44), 5166\u20135177 (2006).","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"18577_CR30","doi-asserted-by":"publisher","first-page":"29871","DOI":"10.1038\/s41598-024-81499-4","volume":"14","author":"M Abdalla","year":"2024","unstructured":"Abdalla, M. et al. Molecular dynamics-based computational investigations on the influence of tumor suppressor p53 binding protein against other proteins\/peptides. Sci. Rep. 14 (1), 29871. https:\/\/doi.org\/10.1038\/s41598-024-81499-4 (2024).","journal-title":"Sci. Rep."},{"issue":"18","key":"18577_CR31","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1080\/07391102.2022.2140201","volume":"41","author":"B Kubra","year":"2023","unstructured":"Kubra, B. et al. Inhibition of the predicted allosteric site of the SARS-CoV-2 main protease through flavonoids. J. Biomol. Struct. Dyn. 41 (18), 9103\u20139120. https:\/\/doi.org\/10.1080\/07391102.2022.2140201 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"18577_CR32","unstructured":"Zhurko, G. A. & Zhurko, D. A. ChemCraft, version 1.6. URL: (2009). http:\/\/www.chemcraftprog.com"},{"issue":"1","key":"18577_CR33","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano, W. L. Pymol: an open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40 (1), 82\u201392 (2002).","journal-title":"Protein Crystallogr."},{"key":"18577_CR34","unstructured":"Jejurikar, B. L. & Rohane, S. H. Drug designing in discovery studio. Asian J Res Chem, 14(2), 135\u2013138. Pawar, S. S., & Rohane, S. H. Review on discovery studio: an important tool for molecular docking. Asian J. Res. Chem, 14, 86\u201388. (2021)."},{"issue":"1","key":"18577_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-022-00796-y","volume":"46","author":"S Ejeh","year":"2022","unstructured":"Ejeh, S., Uzairu, A., Shallangwa, G. A., Abechi, S. E. & Ibrahim, M. T. In Silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approach. Bull. Natl. Res. Centre. 46 (1), 1\u201311 (2022).","journal-title":"Bull. Natl. Res. Centre"},{"issue":"1\u20133","key":"18577_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (1\u20133), 3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"18577_CR37","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. PkCSM: predicting small-molecule Pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58 (9), 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"18577_CR38","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.chphi.2022.100076","volume":"4","author":"EC Agwamba","year":"2022","unstructured":"Agwamba, E. C. et al. Synthesis, characterization, DFT studies, and molecular modeling of Azo dye derivatives as potential candidate for trypanosomiasis treatment. Chem. Phys. Impact. 4, 100076. https:\/\/doi.org\/10.1016\/j.chphi.2022.100076 (2022).","journal-title":"Chem. Phys. Impact"},{"key":"18577_CR39","doi-asserted-by":"publisher","unstructured":"Benjamin, I. et al. Antimalarial potential of naphthalene-sulfonic acid derivatives: molecular electronic properties, vibrational assignments, and in-silico molecular Docking studies. J. Mol. Struct. 133298. https:\/\/doi.org\/10.1016\/j.molstruc.2022.133298 (2022).","DOI":"10.1016\/j.molstruc.2022.133298"},{"key":"18577_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.molstruc.2017.07.093","volume":"1149","author":"Z Zara","year":"2017","unstructured":"Zara, Z. et al. A comparative study of DFT calculated and experimental uv\/visible spectra for Thirty carboline and carbazole based compounds. J. Mol. Struct. 1149, 282\u2013298 (2017).","journal-title":"J. Mol. Struct."},{"key":"18577_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.molstruc.2018.03.090","volume":"1164","author":"BF Rizwana","year":"2018","unstructured":"Rizwana, B. F., Prasana, J. C., Abraham, C. S. & Muthu, S. Spectroscopic investigation, Hirshfeld surface analysis and molecular Docking studies on anti-viral drug Entecavir. J. Mol. Struct. 1164, 447\u2013458 (2018).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"18577_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/vjch.202200063","volume":"61","author":"I Benjamin","year":"2023","unstructured":"Benjamin, I. et al. Hydrazineylidene-3\u2010oxopropanal derivatives as antiviral agents for treatment of HBV and HCV: experimental, DFT, and molecular Docking studies. Vietnam J. Chem. 61 (1), 109\u2013125 (2023).","journal-title":"Vietnam J. Chem."},{"issue":"12","key":"18577_CR43","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.2138\/am-2021-7826","volume":"106","author":"G Ulian","year":"2021","unstructured":"Ulian, G., Moro, D. & Valdr\u00e8, G. Thermodynamic, elastic, and vibrational (IR\/Raman) behavior of mixed type-AB carbonated hydroxylapatite by density functional theory. Am. Mineral. 106 (12), 1928\u20131939 (2021).","journal-title":"Am. Mineral."},{"key":"18577_CR44","doi-asserted-by":"publisher","unstructured":"Eno, E. A. et al. Experimental and computational modeling of the biological activity of benzaldehyde sulphur trioxide as a potential drug for the treatment of alzheimer disease. J. Indian Chem. Soc. 100532. https:\/\/doi.org\/10.1016\/j.jics.2022.100532 (2022).","DOI":"10.1016\/j.jics.2022.100532"},{"key":"18577_CR45","doi-asserted-by":"publisher","first-page":"103946","DOI":"10.1016\/j.mtcomm.2022.103946","volume":"32","author":"H Louis","year":"2022","unstructured":"Louis, H. et al. Modeling of Ca12O12, Mg12O12, and Al12N12 nanostructured materials as sensors for phosgene (Cl2CO). Mater. Today Commun. 32, 103946 (2022).","journal-title":"Mater. Today Commun."},{"issue":"3","key":"18577_CR46","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1039\/D0NJ05397J","volume":"45","author":"YM Issa","year":"2021","unstructured":"Issa, Y. M., Abdel-Latif, S. A., El-Ansary, A. L. & Hassib, H. B. The synthesis, spectroscopic characterization, DFT\/TD-DFT\/PCM calculations of the molecular structure and NBO of the novel charge-transfer complexes of pyrazine schiff base derivatives with aromatic nitro compounds. New J. Chem. 45 (3), 1482\u20131499 (2021).","journal-title":"New J. Chem."},{"issue":"1","key":"18577_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1021\/jm00053a019","volume":"36","author":"RC Wade","year":"1993","unstructured":"Wade, R. C. & Goodford, P. J. Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds. J. Med. Chem. 36 (1), 148\u2013156. https:\/\/doi.org\/10.1021\/jm00053a019 (1993).","journal-title":"J. Med. Chem."},{"key":"18577_CR48","doi-asserted-by":"crossref","unstructured":"Chen, D. et al. Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci. Adv., 2(3), e1501240. (2016).","DOI":"10.1126\/sciadv.1501240"},{"issue":"7104","key":"18577_CR49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nature04975","volume":"442","author":"IC Lorenz","year":"2006","unstructured":"Lorenz, I. C., Marcotrigiano, J., Dentzer, T. G. & Rice, C. M. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 442 (7104), 831\u2013835. https:\/\/doi.org\/10.1038\/nature04975 (2006).","journal-title":"Nature"},{"issue":"1","key":"18577_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cclet.2018.05.013","volume":"30","author":"C Zhu","year":"2019","unstructured":"Zhu, C. et al. Water bridges are essential to neonicotinoids: insights from synthesis, bioassay and molecular modelling studies. Chin. Chem. Lett. 30 (1), 255\u2013258 (2019).","journal-title":"Chin. Chem. Lett."},{"key":"18577_CR51","doi-asserted-by":"crossref","unstructured":"Patil, R. et al. Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PloS One, 5(8), e12029. (2010).","DOI":"10.1371\/journal.pone.0012029"},{"issue":"3","key":"18577_CR52","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/ijms23031771","volume":"23","author":"S Rampogu","year":"2022","unstructured":"Rampogu, S., Lee, G., Park, J. S., Lee, K. W. & Kim, M. O. Molecular Docking and molecular dynamics simulations discover Curcumin analogue as a plausible dual inhibitor for SARS-CoV-2. Int. J. Mol. Sci. 23 (3), 1771. https:\/\/doi.org\/10.3390\/ijms23031771 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"18577_CR53","doi-asserted-by":"publisher","first-page":"626363","DOI":"10.3389\/fmolb.2020.626363","volume":"7","author":"C Savojardo","year":"2021","unstructured":"Savojardo, C., Manfredi, M., Martelli, P. L. & Casadio, R. Solvent accessibility of residues undergoing pathogenic variations in humans: from protein structures to protein sequences. Front. Mol. Biosci. 7, 626363 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"18577_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11101-021-09785-x","volume":"21","author":"G Renda","year":"2022","unstructured":"Renda, G., G\u00f6kkaya, \u0130. & \u015e\u00f6hreto\u011flu, D. Immunomodulatory properties of triterpenes. Phytochem Rev. 21, 537\u2013563. https:\/\/doi.org\/10.1007\/s11101-021-09785-x (2022).","journal-title":"Phytochem Rev."},{"issue":"4","key":"18577_CR55","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1128\/JVI.03385-14","volume":"89","author":"K Saito","year":"2015","unstructured":"Saito, K. et al. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus. J. Virol. 89 (4), 2220\u20132232. https:\/\/doi.org\/10.1128\/JVI.03385-14 (2015a).","journal-title":"J. Virol."},{"issue":"4","key":"18577_CR56","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1128\/JVI.03385-14","volume":"89","author":"K Saito","year":"2015","unstructured":"Saito, K. et al. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus. J. Virol. 89 (4), 2220\u20132232. https:\/\/doi.org\/10.1128\/JVI.03385-14 (2015).","journal-title":"J. Virol."},{"issue":"10","key":"18577_CR57","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.3390\/ijms23105659","volume":"23","author":"M Marinescu","year":"2022","unstructured":"Marinescu, M. & Popa, C. V. Pyridine compounds with antimicrobial and antiviral activities. Int. J. Mol. Sci. 23 (10), 5659. https:\/\/doi.org\/10.3390\/ijms23105659 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"18577_CR58","unstructured":"Corrigan, T. S. Synthetic Efforts Towards Small Molecule Solutions for Organophosphorus Nerve Agent Poisoning and Protease Inhibition (Doctoral dissertation, The Ohio State University). (2017)."},{"key":"18577_CR59","unstructured":"Fan, H. Synthesis of Phosphonate and Thiophosphonate Peptide Analogs as Inhibitors of Carboxypeptidase A (Louisiana State University and Agricultural & Mechanical College, 2000)."},{"issue":"1","key":"18577_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/14756366.2018.1506772","volume":"34","author":"M Skore\u0144ski","year":"2019","unstructured":"Skore\u0144ski, M., Milewska, A., Pyr\u0107, K., Sie\u0144czyk, M. & Oleksyszyn, J. Phosphonate inhibitors of West nile virus NS2B\/NS3 protease. J. Enzyme Inhib. Med. Chem. 34 (1), 8\u201314. https:\/\/doi.org\/10.1080\/14756366.2018.1506772 (2019).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"9","key":"18577_CR61","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1021\/cr200060g","volume":"111","author":"EJ Barreiro","year":"2011","unstructured":"Barreiro, E. J., K\u00fcmmerle, A. E. & Fraga, C. A. The methylation effect in medicinal chemistry. Chem. Rev. 111 (9), 5215\u20135246 (2011).","journal-title":"Chem. Rev."},{"issue":"3","key":"18577_CR62","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12020-023-03458-9","volume":"82","author":"M J\u00f3zkowiak","year":"2023","unstructured":"J\u00f3zkowiak, M. et al. Steroidogenic activity of liposomal methylated Resveratrol analog 3,4,5,4\u2019- tetramethoxystilbene (DMU-212) in human luteinized granulosa cells in a primary three- dimensional in vitro model. Endocrine 82 (3), 681\u2013694. https:\/\/doi.org\/10.1007\/s12020-023-03458-9 (2023).","journal-title":"Endocrine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18577-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:06:02Z","timestamp":1774307162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18577-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["18577"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18577-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9568"}}